Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Oct 1, 2026, 8:29 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1–24 of 57 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Reduce the Incidence of OR Contamination/Infection Transmission; Clear all

Conditions: Delirium, Sleep Fragmentation
Interventions: Foam Earplugs, Noise Canceling Headphones; Device
Lead sponsor: Wake Forest University; Other
Eligibility: 18 Years and older
Enrollment: 8 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2015
U.S. locations: 1
States / cities: Winston-Salem, North Carolina

Conditions: Stress Incontinence
Interventions: Nitrofurantoin, Placebo; Drug · Other
Lead sponsor: University of Missouri-Columbia; Other
Eligibility: 18 Years and older · Female only
Enrollment: 161 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2008 – 2010
U.S. locations: 1
States / cities: Temple, Texas

Conditions: New Onset Atrial Fibrillation, Anesthesia, Local, Cardiac Disease
Interventions: Ropivacaine 0.2% Injectable Solution; Drug
Lead sponsor: University of Minnesota; Other
Eligibility: 18 Years and older
Enrollment: 32 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2025
U.S. locations: 1
States / cities: Minneapolis, Minnesota

Conditions: Delirium, Sleep Hygiene
Interventions: MMSH (Multi-Modal Sleep Hygiene) Bundle; Other
Lead sponsor: Farhaan S. Vahidy; Other
Eligibility: 70 Years and older
Enrollment: 10,890 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2029
U.S. locations: 5
States / cities: Baytown, Texas • Houston, Texas • Sugarland, Texas

Conditions: Diarrhea, Malaria
Interventions: Zinc sulphate, Placebo; Dietary Supplement · Other
Lead sponsor: United States Army Research Institute of Environmental Medicine; Federal
Eligibility: 18 Years to 55 Years
Enrollment: 500 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2007 – 2008
U.S. locations: 2
States / cities: Natick, Massachusetts • Grand Forks, North Dakota

Conditions: Pregnancy
Interventions: Bupivacaine, Fentanyl; Drug
Lead sponsor: St. Luke's-Roosevelt Hospital Center; Other
Eligibility: 18 Years to 48 Years · Female only
Enrollment: 170 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015 – 2017
U.S. locations: 1
States / cities: New York, New York

Conditions: Stroke, Cerebrovascular Accident, Hemiparesis
Interventions: Armodafinil, Placebo; Drug
Lead sponsor: Burke Rehabilitation Hospital; Other
Eligibility: 18 Years and older
Enrollment: 19 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2015
U.S. locations: 1
States / cities: White Plains, New York

Conditions: Hypoventilation, Hypoxia
Interventions: Nellcor NPB-70 Capnograph; Device
Lead sponsor: Yale University; Other
Eligibility: 1 Year to 20 Years
Enrollment: 167 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2012
U.S. locations: 1
States / cities: New Haven, Connecticut

Conditions: Critically Ill Patients, Cardiovascular Surgery Telemetry Patients
Interventions: Disposable ECG-LW; Other
Lead sponsor: The Cleveland Clinic; Other
Eligibility: Not listed
Enrollment: 4,056 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2013
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: Atrial Fibrillation
Interventions: TZD reducing the incidence of atrial arrhythmias; Procedure
Lead sponsor: Emory University; Other
Eligibility: 18 Years to 65 Years
Enrollment: 600 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2007
U.S. locations: 3
States / cities: Atlanta, Georgia • Decatur, Georgia

Conditions: Urinary Retention Postoperative
Interventions: Uroselective alpha-1-adrenergic receptor antagonist, Placebo; Drug · Other
Lead sponsor: Mayo Clinic; Other
Eligibility: 35 Years and older
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Hypoxia, Endoscopy, Anesthesia Morbidity
Interventions: Nasal Mask, Control: Nasal Cannula; Device
Lead sponsor: Johns Hopkins University; Other
Eligibility: 18 Years to 100 Years
Enrollment: 111 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2019
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Trauma Injury, Thromboembolism, Venous Thromboembolism
Interventions: Thrombate infusion, Placebo; Drug
Lead sponsor: Bryan Cotton; Other
Eligibility: 18 Years and older
Enrollment: 314 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2027
U.S. locations: 4
States / cities: Aurora, Colorado • Miami, Florida • Nashville, Tennessee + 1 more

Conditions: Transmission, Other/Miscellaneous
Interventions: Slippers; Behavioral
Lead sponsor: Louis Stokes VA Medical Center; Federal
Eligibility: 18 Years and older
Enrollment: 34 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2021
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: Postoperative Atrial Fibrillation
Interventions: Not listed
Lead sponsor: George Washington University; Other
Eligibility: 18 Years to 100 Years
Enrollment: 160 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2008 – 2011
U.S. locations: 2
States / cities: Washington D.C., District of Columbia

Conditions: Oral Mucositis (Ulcerative), Oral Mucositis (Ulcerative) Due to Radiation, Oral Mucositis (Ulcerative) Due to Antineoplastic Therapy, Head and Neck Cancer
Interventions: Photobiomodulation, Routine Oral Care and Analgesia; Device · Other
Lead sponsor: MuReva Phototherapy Inc.; Industry
Eligibility: 22 Years and older
Enrollment: 85 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2024
U.S. locations: 12
States / cities: Birmingham, Alabama • Long Beach, California • Miami, Florida + 9 more

Conditions: Chronic Kidney Disease, Obstructive Sleep Apnea
Interventions: CPAP/autopap; Device
Lead sponsor: University of South Florida; Other
Eligibility: 19 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2014
U.S. locations: 1
States / cities: Tampa, Florida

Conditions: Nosocomial Bacteremia, Nosocomial Fungemia, MRSA Colonization, MRSA Infection, VRE Colonization, VRE Infection
Interventions: Daily bathing with Chlorhexidine based product; Behavioral
Lead sponsor: Hunter Holmes Mcguire Veteran Affairs Medical Center; Federal
Eligibility: 18 Years and older
Enrollment: 5,300 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2004 – 2006
U.S. locations: 4
States / cities: Baltimore, Maryland • St Louis, Missouri • New York, New York + 1 more

Conditions: Type 2 Diabetes Mellitus
Interventions: Saxagliptin, Placebo; Drug
Lead sponsor: AstraZeneca; Industry
Eligibility: 40 Years and older
Enrollment: 18,206 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2013
U.S. locations: 202
States / cities: Birmingham, Alabama • Phoenix, Arizona • Tempe, Arizona + 199 more

Conditions: Sunburn, Erythema, Sun Protection
Interventions: Goal attainment; Behavioral
Lead sponsor: Northwestern University; Other
Eligibility: 18 Years to 70 Years
Enrollment: 164 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2020
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Contrast Induced Kidney Injury.
Interventions: sodium bicarbonate; Drug
Lead sponsor: MD Scientific; Industry
Eligibility: 18 Years and older
Enrollment: 391 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2012
U.S. locations: 17
States / cities: Kissimmee, Florida • St. Petersburg, Florida • Rome, Georgia + 13 more

Conditions: Contrast Induced Nephropathy
Interventions: RenalGuard Therapy, Standard Therapy; Device · Drug
Lead sponsor: CardioRenal Systems, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 326 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2024
U.S. locations: 30
States / cities: Birmingham, Alabama • Torrance, California • Washington D.C., District of Columbia + 23 more

Conditions: Postoperative Urinary Retention
Interventions: Tamsulosin hydrochloride, Placebo; Drug · Other
Lead sponsor: Mayo Clinic; Other
Eligibility: 35 Years and older
Enrollment: 90 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2019
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Urinary Tract Infections, Kidney Transplant; Complications
Interventions: Double Voiding, Regular Voiding; Other
Lead sponsor: Weill Medical College of Cornell University; Other
Eligibility: 18 Years and older
Enrollment: 438 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2027
U.S. locations: 1
States / cities: New York, New York

Search by objective public record fields.

Direct Noise Reduction in the Intensive Care Units (ICU) Using Earplugs and Noise Canceling Headphones

Does Treatment With Macrobid Reduce Urinary Tract Infections in Patients Receiving a Sub-Urethral Sling for Incontinence

Paravertebral Block to Reduce the Incidence of New Onset Atrial Fibrillation After Cardiac Surgery

Modifying the Inpatient Environment to Reduce Delirium in Older Adults

Zinc Supplementation to Reduce Diarrhea Rates in Adults in Western Kenya.

Optimizing Dose of Bupivacaine in Combined Spinal Epidurals To Reduce Side Effects

Combining Armodafinil With Neuro-rehabilitation to Improve Neurological Recovery and Reduce Disability Post-Stroke

Using Capnography to Reduce Hypoxia During Pediatric Sedation

ECG Leadwires: Disposable Versus Cleaned, Reusable

A Retrospective Study of the Role of Thiazolidinediones to Reduce the Incidence of Atrial Arrhythmias

Uroselective Alpha-1-Antagonist to Reduce the Incidence and Duration of Postoperative Urinary Retention Following Spine Surgery

Nasal Continuous Positive Airway Pressure Versus Standard Care During Procedural Sedation for Gastrointestinal Endoscopy

Antithrombin to Improve Thromboprophylaxis and Reduce the Incidence of Trauma-Related Venous Thromboembolism

Slippers to Reduce Transfer From Floors to Surfaces

Prevention of Postoperative Atrial Fibrillation

Photobiomodulation to Demonstrate Safety and Reduce the Incidence of Oral Mucositis in Adult Head & Neck Cancer Patients

Using Continuous Positive Airway Pressure to Reduce the Incidence of Acute Kidney Injury in Hospitalized Patients With Chronic Kidney Disease

The Impact of Chlorhexidine-Based Bathing on Nosocomial Infections

Does Saxagliptin Reduce the Risk of Cardiovascular Events When Used Alone or Added to Other Diabetes Medications

UV Exposure Assessed With Wearable Sensor and Sun Protection

Evaluation of Sodium Bicarbonate to Reduce the Incidence of Contrast Induced Chronic Kidney Injury in Patients With Kidney Disease

Evaluation of RenalGuard® System to Reduce the Incidence of Contrast Induced Nephropathy in At-Risk Patients

Use of Tamsulosin to Reduce the Incidence and Duration of Postoperative Urinary Retention Following Spine Surgery

Double Voiding and Post-transplant UTI